Subscribe
S078 DTx series 5/5: Diabetes clinical trials on Whatsapp? (Abhishek Shah)

Faces of Digital Health

S078 DTx series 5/5: Diabetes clinical trials on Whatsapp? (Abhishek Shah)

Wellthy is one of Asia's leading digital therapeutics companies that inspires and enables patients to prevent, reverse and control chronic diseases. It works with pharmaceutical, medical devices companies, payors and…
May 1, 2020

S078 DTx series 5/5: Diabetes clinical trials on Whatsapp? (Abhishek Shah)

Wellthy is one of Asia’s leading digital therapeutics companies that inspires and enables patients to prevent, reverse and control chronic diseases. It works with pharmaceutical, medical devices companies, payors and healthcare providers to improve health outcomes. With active therapeutic areas in diabetes and cardiology, it has published real-world evidence across 20 publications in leading peer-reviewed journals and global conferences. In this episode, the last one of the 5-part series about digital therapeutics, Abhishek Shah, the CEO and Founder of Wellthy, on of the largest DTx companies in Asia, talks about the importance of understanding that healthcare is always local and shared some vivid examples of different rules of engagement with users in India compared to the West.
Recap: https://www.facesofdigitalhealth.com/blog/s078-dtx-series-55-chronic-disease-management-in-india-abhishek-shah
Wellthy: https://wellthytherapeutics.com/about

Listen on your favorite player

New to Podcasts? It's easy to get started!

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Proudly supported by:

cover
Javier Lozano - Market-Creating Innovation for Diabetes Care an inspiring conversation with Javier Lozano, Founder and CEO of Clínicas del Azúcar, a growing chain of "one-stop shops" for diabetes care in Mexico.